Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
Talphera (Nasdaq: TLPH), a specialty pharmaceutical company, has announced its participation in the 2024 Maxim Healthcare Virtual Summit. The company's management will engage in a fireside chat and be available for one-on-one meetings with registered investors during the event, which is scheduled for October 15-17, 2024.
Key details of Talphera's participation include:
- Event: 2024 Maxim Healthcare Virtual Summit
- Date: October 16, 2024
- Time: 3:00 PM ET / 12:00 Noon PT
Talphera focuses on developing and commercializing innovative therapies for use in medically supervised settings. Investors and interested parties can access the fireside chat through the provided webcast link.
Talphera (Nasdaq: TLPH), una società farmaceutica specializzata, ha annunciato la sua partecipazione al Virtual Summit Maxim Healthcare 2024. La dirigenza dell'azienda parteciperà a un colloquio informale e sarà disponibile per incontri individuali con gli investitori registrati durante l'evento, previsto per il 15-17 ottobre 2024.
I dettagli principali della partecipazione di Talphera includono:
- Evento: Virtual Summit Maxim Healthcare 2024
- Data: 16 ottobre 2024
- Ora: 15:00 ET / 12:00 PT
Talphera si concentra sullo sviluppo e sulla commercializzazione di terapie innovative destinate a essere utilizzate in contesti medicalmente supervisionati. Gli investitori e le parti interessate possono accedere al colloquio informale tramite il link per la trasmissione in streaming fornito.
Talphera (Nasdaq: TLPH), una compañía farmacéutica especializada, ha anunciado su participación en el Summit Virtual de Maxim Healthcare 2024. La gerencia de la compañía participará en una charla informal y estará disponible para reuniones individuales con inversores registrados durante el evento, que está programado para el 15-17 de octubre de 2024.
Los detalles clave de la participación de Talphera incluyen:
- Evento: Summit Virtual de Maxim Healthcare 2024
- Fecha: 16 de octubre de 2024
- Hora: 3:00 PM ET / 12:00 PM PT
Talphera se enfoca en desarrollar y comercializar terapias innovadoras para su uso en entornos supervisados médicamente. Los inversores y partes interesadas pueden acceder a la charla informal a través del enlace de transmisión proporcionado.
탈페라 (Nasdaq: TLPH)는 특수 제약 회사로서 2024 맥심 헬스케어 가상 정상 회담에 참가한다고 발표했습니다. 회사 경영진은 이벤트 기간 동안 등록된 투자자들과의 일대일 회의에서 대담을 진행할 예정이며, 이 행사는 2024년 10월 15일부터 17일까지 예정되어 있습니다.
탈페라의 참가 주요 사항은 다음과 같습니다:
- 이벤트: 2024 맥심 헬스케어 가상 정상 회담
- 날짜: 2024년 10월 16일
- 시간: 동부 표준시 오후 3시 / 태평양 표준시 정오 12시
탈페라는 의료 감독을 받는 환경에서 사용하기 위한 혁신적인 치료제를 개발하고 상용화하는 데 집중하고 있습니다. 투자자와 관심 있는 분들은 제공된 웹캐스트 링크를 통해 대담에 접속할 수 있습니다.
Talphera (Nasdaq: TLPH), une société pharmaceutique spécialisée, a annoncé sa participation au Sommet Virtuel Maxim Healthcare 2024. La direction de l'entreprise participera à une discussion informelle et sera disponible pour des réunions individuelles avec les investisseurs inscrits pendant cet événement, qui est prévu du 15 au 17 octobre 2024.
Les principaux détails de la participation de Talphera incluent :
- Événement : Sommet Virtuel Maxim Healthcare 2024
- Date : 16 octobre 2024
- Heure : 15h00 ET / 12h00 PT
Talphera se concentre sur le développement et la commercialisation de thérapies innovantes destinées à être utilisées dans des environnements médicaux supervisés. Les investisseurs et les parties intéressées peuvent accéder à la discussion informelle via le lien de webdiffusion fourni.
Talphera (Nasdaq: TLPH), ein spezialisiertes Pharmaunternehmen, hat seine Teilnahme am Maxim Healthcare Virtuellen Gipfel 2024 angekündigt. Das Management des Unternehmens wird an einem informellen Gespräch teilnehmen und während der Veranstaltung für Einzelgespräche mit registrierten Investoren zur Verfügung stehen, die vom 15. bis 17. Oktober 2024 stattfindet.
Wichtige Details zu Talpheras Teilnahme sind:
- Veranstaltung: Maxim Healthcare Virtueller Gipfel 2024
- Datum: 16. Oktober 2024
- Uhrzeit: 15:00 Uhr ET / 12:00 Uhr PT
Talphera konzentriert sich auf die Entwicklung und Vermarktung innovativer Therapien zur Anwendung in medizinisch überwachten Umgebungen. Investoren und Interessierte können über den bereitgestellten Webcast-Link auf das informelle Gespräch zugreifen.
- None.
- None.
Event: 2024 Maxim Healthcare Virtual Summit
Date: October 16, 2024
Time: 3:00 PM ET / 12:00 Noon PT
Webcast link: 2024 Maxim Healthcare Virtual Summit
About Talphera, Inc.
Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Talphera's lead product candidate, Niyad™ is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption (IDE) as an anticoagulant for the extracorporeal circuit, and has received Breakthrough Device Designation status from the
This release is intended for investors only. For additional information about Talphera, please visit www.talphera.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/talphera-to-participate-in-fireside-chat-at-the-2024-maxim-healthcare-virtual-summit-302270671.html
SOURCE Talphera, Inc.
FAQ
When is Talphera (TLPH) participating in the 2024 Maxim Healthcare Virtual Summit?
What type of event is Talphera (TLPH) participating in at the 2024 Maxim Healthcare Virtual Summit?
Will Talphera (TLPH) be available for investor meetings during the 2024 Maxim Healthcare Virtual Summit?
What is the focus of Talphera (TLPH) as a pharmaceutical company?
